Aducanumab: Hype, or Headway for the Alzheimer’s Amyloid Hypothesis?

Moderator:

  • Ginger S. Johnson, CEO, Defined Health

Panelist:

  • Norman R. Relkin, MD, PhD, Associate Professor of Clinical Neurology, Weill Cornell Medical College